Phillips 66 heads into its May 13 earnings date with the Street turning more constructive, shorts retreating at pace, and the stock clawing back most of a bruising April.
The biggest structural shift this week is on the analyst side. Morgan Stanley upgraded PSX to Overweight from Equal-Weight on April 24, lifting its target from $147 to $174 — a move that carries weight given how few bellwether firms have been willing to get outright bullish on refiners this year. The upgrade didn't come in isolation. A cluster of target raises has built up over the past month: UBS sits at $212 with a Buy, Wells Fargo at $201 with Overweight, Raymond James at $205 Outperform. Citigroup, Barclays, and Piper Sandler have also lifted targets while keeping neutral ratings, signalling the bears aren't fully retreating. The consensus mean target is $184.53, about 6% above Wednesday's close of $173.49, which makes the Street's aggregate stance modestly constructive rather than aggressively bullish. One data point worth noting: the analyst recommendation divergence ranks in the 96th percentile versus the broader market — meaning PSX is unusually polarising between believers and sceptics.
Short positioning tells a less contentious story. Bears have been covering steadily. Short interest as a percentage of the free float has dropped to 1.55%, down from roughly 2% a month ago and from above 2% in mid-March. The week-on-week decline is nearly 5%, with the sharper step-down arriving around April 23 as short positions fell by around 280,000 shares in a single session. Availability in the lending market remains loose — borrow conditions are not remotely tight here — though cost to borrow did jump to 0.55% on April 29, its highest reading of the past six weeks. That's still a trivially cheap rate by any absolute measure. The ORTEX short score is 29.7, near the lower end of its recent range, confirming that the overall short-side pressure on PSX is ebbing, not building.
Options traders are somewhat more cautious. The put/call ratio moved to 0.93 on April 29, above its 20-day average of 0.88 by roughly 1.7 standard deviations — not an extreme, but the directional drift toward defensive positioning is clear. The 52-week high for the PCR is 1.22, so there is room to go much further if sentiment deteriorates ahead of the May 13 print. For now, the options signal reads as measured hedging rather than outright fear — consistent with investors who are broadly positive but want some downside protection going into results.
The valuation backdrop is mixed. At 11.3x trailing earnings and 8.1x EV/EBITDA, PSX isn't cheap for a refiner facing margin pressure, and the EV/EBITDA multiple has actually compressed slightly over the past month even as the stock recovered. The price-to-book has retreated by about 0.2 turns over 30 days. Where the stock does score well is on EPS momentum and earnings quality: EPS surprise ranks in the 93rd percentile, and 90-day EPS momentum is in the 71st percentile. The bear case centres on weaker Q1 refining margins — analysts cut Q1 EPS estimates to around $1.75 and EBITDA to roughly $759 million before the print — while the bull case rests on a 99% refinery utilisation rate in Q4 and a pathway to $4.5 billion EBITDA by 2027 as recently acquired assets begin to contribute. The dividend score, at the 92nd percentile, remains a clear support point for income-oriented holders.
Insider activity skews negative on a recent basis, though the reads are mixed. CFO Kevin Mitchell sold over $6.8 million worth of stock across two March transactions. Executive Vice President Don Baldridge also sold in both February and April. Against that, one director added a small position at $173.20 in mid-March — almost exactly where the stock closed this week. The 90-day net insider position is modestly positive in share terms once awards are included, but cash-sale activity from the CFO at prices well above the current level is a detail worth tracking. Closest peers have had a strong week: MPC gained 8.9%, DINO surged 10.9%, and DK led the group with an 18.4% weekly move, suggesting the broader refiner re-rating is providing meaningful tailwind for PSX rather than any company-specific catalyst.
The next hard date is May 13, when the market gets to test whether the margin recovery the Street has been pricing in actually materialised in Q1.
See the live data behind this article on ORTEX.
Open PSX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
